SCAI QIT CME Webinar Series
The SCAI Quality Improvement Toolkit (SCAI-QIT) was developed by SCAI to provide interventional cardiologists with a tool to practice evidence - based guidelines - driven care. The tools contained in SCAI-QIT help interventional cardiologists and catheterization laboratory teams identify opportunities for improvement and changes that will positively impact patient outcomes.
After completing this program, participants should be able to;
- Identify appropriate quality improvement programs in catheterization laboratories based on clinical guidelines;
- Apply evidence-based practice to existing quality improvement programs;
- Manage laboratories to tailor QI programs to local environments.
METHOD OF PARTICIPATION AND CONTINUING MEDICAL EDUCATION CREDIT
Certificates of Completion/Attendance will be provided to participants who have reviewed the presentations and completed the online evaluation\quiz. The course will generate a certificate for individual presentations; if you have any questions regarding continuing medical education credits, please contact Sylvia Pérez at firstname.lastname@example.org.
ORIGINAL RELEASE DATE: May 20, 2012
TERMINATION DATE: April 01, 2015
LAST REVIEW DATE: April 01, 2013
Estimated Time to Complete the Educational Activity 7 hours
PHYSICIANS: The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society for Cardiovascular Angiography and Interventions designates this enduring education activity for a maximum of 7.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
In order to view and hear online webinars, your computer and internet connection need to meet certain minimum requirements.
Please check that your computer and software meets or exceeds these specifications:
- Windows XP, Mac OS X 10.2
- 1GB of RAM memory
- CPU 1 GHz
- Monitor 800x600 pixels (1024x768 strongly recommended)
- DSL or faster internet connection
- Up-to-date web browser software, such as FireFox 15+, or Internet Explorer 8+, Safari 4+. IE6 is NOT supported.
- Adobe Flash Plugin, newest version
- Working audio card and speakers
CONTENT VALIDATION STATEMENT
The Society for Cardiovascular Angiography and Interventions accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care.
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
As a provider of continuing education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society's policy to ensure balance, independence, objectivity and scientific rigor in all of its programs. All participating faculty, course directors, and planning committee members are required to disclose to SCAI any financial relationships related to the subject matter of the program or committee in which they are participating. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of the disclosure is not to prevent the planner or presenter from being involved in the activity, but rather to promote transparency and provide participants with information on which they can make their own judgments.
Christopher J. White, M.D., FSCAI (Advisory Board / Board Member: Neovasc; St. Jude; Baxter Cellular Therapy)
Sunil V. Rao, M.D., FSCAI (Consultant: Volcano Corporation; Astra Zeneca; Daiichi Sankyo Lilly; Zoll; Terumo Medical; The Medicines Company. Grants or Research Support: Ikaria; Abbott Vascular)
Steven R. Bailey, MD, FSCAI (Editor-in-Chief: Cathterization and Cardiovascular Interventions; Speakers Bureau: Edwards; BSCI; Research Support: Abbott; SCAI; Advisory Board: Biostar; Bio2)
Thomas M. Bashore, MD, FSCAI (Disclosed no conflict of interest)
James Blankenship, MD, FSCAI (Disclosed no conflict of interest)
Lyndon Box, MD, FSCAI (Disclosed no conflict of interest)
Charles E. Chambers, MD, FSCAI (Disclosed no conflict of interest)
Kirk Garratt, MD, FSCAI (Shareholder: Global Delivery Systems; MedLogics; Arstasis; and Infarct Reduction. Speakers Bureau/Advisory Board/Board Member: Boston Scientific Corp; The Medicines Company; Medtronic; Daiichi-Sankyo, Inc.; Abbott Vascular.)
Kalon Ho, MD, FSCAI (Boston Scientific Corporation: Service on an independent clinical events committee adjudicating events for BSC trials.)
Manesh R. Patel, MD, FSCAI (Grants: NHLB, AHRQ and Johnson & Johnson; Advisory Board/ Board member/Consultant: Baxter; Pleuristem; CSI; Genzyme; Ortho-McNeil Jansen; Astra Zeneca)
Srihari Naidu, MD, FSCAI (Advisory Board/ Board member/Consultant: The Medicines Company; Abiomed, Inc.)
Bonnie H. Weiner, MD, FSCAI (Consultant: Accreditation for Cardiovascular Excellence; ArtiCure; Atheromed; Boston Biomedical Associates; Creganna-Tactx. Shareholder: Imaging Core Lab Services)
Steve Yakubov, MD, FSCAI (Advisory Board/ Board member/Consultant: Medtronic; Boston Scientific; Abbott Vascular; Boehringer Ingleheim. Speakers Bureau: SentreHEART)
The SCAI Quality Improvement Toolkit was originally developed with support from Daiichi Sankyo, Inc. and Lilly USA, LLC. This program is also supported by AstraZeneca. The Society gratefully acknowledges this support, while taking sole responsibility for all content developed and disseminated through this effort.